Differential activation of protein kinase C isoforms by euxanthone, revealed by an in vivo yeast phenotypic assay

Planta Med. 2002 Nov;68(11):1039-41. doi: 10.1055/s-2002-35655.

Abstract

The protein kinase C (PKC) modulatory effects of euxanthone, isolated from the wood of Cratoxylum maingayi, on isoforms alpha, betaI, delta, eta and zeta were characterised using an alternative in vivo yeast phenotypic assay. The present study shows that euxanthone can activate isoforms alpha, betaI, delta, eta and zeta, being more effective on PKC-betaI, -delta, -eta and -zeta than the established PKC activators used (the phorbol ester PMA and arachidonic acid for PKC-zeta). Furthermore, euxanthone presents differences on its potency towards individual PKC isoforms, showing a remarkable selectivity for PKC-zeta. These results can help to clarify the molecular basis of the euxanthone-mediated effects.

Publication types

  • Letter

MeSH terms

  • Clusiaceae*
  • Dose-Response Relationship, Drug
  • Humans
  • Inhibitory Concentration 50
  • Isoenzymes / drug effects
  • Isoenzymes / metabolism
  • Phenotype
  • Phytotherapy*
  • Protein Kinase C / drug effects*
  • Protein Kinase C / metabolism
  • Xanthenes / administration & dosage
  • Xanthenes / pharmacology*
  • Xanthones*
  • Yeasts / drug effects*
  • Yeasts / genetics
  • Yeasts / metabolism

Substances

  • Isoenzymes
  • Xanthenes
  • Xanthones
  • euxanthone
  • Protein Kinase C